STOCK TITAN

PTC Therapeutics' Mary Frances Harmon Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

PTC Therapeutics, based in South Plainfield, N.J., announced that Mary Frances Harmon, its Senior Vice President of Corporate and Patient Relations, has been named one of the most inspiring leaders in life sciences by PharmaVOICE magazine. Harmon is recognized for her dedication to improving patient lives and her work in establishing relationships with patients and advocacy groups. With over 30 years in the pharmaceutical industry, she has initiated programs like the STRIVE awards to support Duchenne muscular dystrophy patients. PTC continues to emphasize its commitment to patient-focused initiatives.

Positive
  • Mary Frances Harmon recognized by PharmaVOICE as a leading figure in life sciences.
  • STRIVE awards initiative supports Duchenne muscular dystrophy patient community.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Aug. 6, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to announce that its Senior Vice President of Corporate and Patient Relations, Mary Frances Harmon, has been named to PharmaVOICE magazine's annual list of the most inspiring people in the life sciences industry. Mary Frances is recognized for her inspirational qualities, passion and conviction for the industry, and dedication to improving the lives of patients.

"Throughout her tenure at PTC, Mary Frances has consistently served as an inspiration to us, the patients, and their families - performing from a place of genuine care and compassion," said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics. "With her long and dedicated experience in patient advocacy, she has been vital in establishing and growing relationships with patients, advocacy groups and caregivers so that PTC can better serve the needs of patients. We could not be prouder of Mary Frances and we are all thrilled that she will receive this well-earned recognition from PharmaVOICE."

Mary Frances has over 30 years of experience in the pharmaceutical industry and currently oversees strategic and operational leadership for corporate communications, government affairs, advocacy, and patient communications and engagement, which is essential in PTC's commitment to patient families. Her work helps create a unified vision for patient and government relations and implementing programs with patient groups. During her first year at PTC, Mary Frances launched the Strategies to Realize Innovation, Vision, and Empowerment (STRIVE) awards, which supports initiatives benefitting the Duchenne muscular dystrophy patient community. STRIVE drives innovation and awareness within the medical community and has awarded funding to 28 patient advocacy organizations worldwide.

To learn more about Mary Frances' work at PTC and her PharmaVOICE 100 recognition, please visit the July/August 2020 online digital edition of the magazine: PharmaVOICE July/August 2020

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.

For More Information:

Investors:
Alex Kane
+1 (908) 912-9643

Media:
Jane Baj
+1 (908) 912-9167
jbaj@ptcbio.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ptc-therapeutics-mary-frances-harmon-named-one-of-the-most-inspiring-leaders-in-life-sciences-by-pharmavoice-magazine-301107383.html

SOURCE PTC Therapeutics, Inc.

FAQ

Who was recognized by PharmaVOICE magazine in August 2020?

Mary Frances Harmon, Senior Vice President of PTC Therapeutics, was recognized by PharmaVOICE magazine.

What is the significance of the STRIVE awards initiated by PTC Therapeutics?

The STRIVE awards support initiatives benefiting the Duchenne muscular dystrophy patient community.

How long has Mary Frances Harmon been in the pharmaceutical industry?

Mary Frances Harmon has over 30 years of experience in the pharmaceutical industry.

What company does Mary Frances Harmon work for?

Mary Frances Harmon works for PTC Therapeutics.

What role does Mary Frances Harmon hold at PTC Therapeutics?

Mary Frances Harmon is the Senior Vice President of Corporate and Patient Relations at PTC Therapeutics.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN